FindTrial
Sign In

A study of AI conversation in telemedicine for Parkinson's disease

A Randomized study of AI dialogue in telemedicine for Parkinson's disease - A Randomized study of AI dialogue in telemedicine for Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039698
Enrollment
20
Registered
2020-03-04
Start date
2019-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

Daily,for five months,talking with AI chatbot Once or twice a week,for five months,talking with a doctor

Sponsors

Juntendo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1, Patients who satisfy the diagnostic criteria for Parkinson's disease.(MDS diagnostic criteria) 2, Ages between 20 and 80 3, Japanese and native language is Japanese 4, Participants who have been given sufficient explanations to participate in this study,and with sufficient understanding and who have given their informed consent

Exclusion criteria

Exclusion criteria: 1, Patients who have been diagnosed with dementia (MMSE less than 20 points) 2, Patients who have a trouble to hear the sound of the iPad 3, In addition,patients who are judges by the investigation to be inappropriate as subjects

Design outcomes

Primary

MeasureTime frame
Sound parameters and Facial expression features during the talking between the subject and the doctor.—

Countries

Japan

Contacts

Public ContactMayuko Ogawa

Juntendo University Graduate School of Medicine Department of Nerodegenerative and Dementied Disorders

maogawa@juntendo.ac.jp0358023111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026